Noll A, Roggenkamp A, Heesemann J, Autenrieth I B
Institut für Hygiene und Mikrobiologie Universität Würzburg, Germany.
Infect Immun. 1994 Jul;62(7):2784-91. doi: 10.1128/iai.62.7.2784-2791.1994.
To investigate the role of heat shock proteins (HSP) of Yersinia enterocolitica for the host immune response against this pathogen, we cloned and expressed a 60-kDa HSP of Y. enterocolitica serotype O8. A fragment of Y. enterocolitica O8 HSP60 encoded by amino acids 90 to 286 was sequenced and showed more than 90% homology with HSP60 of Y. enterocolitica O3 and GroEL of Escherichia coli and 59% homology with HSP65 of Mycobacterium bovis. The arthritogenic T-cell epitope of mycobacterial HSP65 (amino acid residues 180 to 188) was not found on Yersinia HSP60. To determine whether Yersinia HSP60 is an immunodominant antigen, the immune responses of Yersinia-infected C57BL/6 mice were analyzed. Yersinia-infected mice evolved a significant serum antibody and splenic T-cell response against Yersinia HSP60. CD4+ alpha beta T-cell clones which were generated from splenic T cells isolated from either Yersinia-infected or Yersinia HSP60-immunized mice, recognized both heat-killed Yersinia serotypes O3 and O8 as well as recombinant Yersinia HSP60 but not heat-killed Yersinia pseudotuberculosis, Salmonella typhimurium, or recombinant HSP65 of Mycobacterium bovis. The adoptive transfer of HSP60-reactive T-cell clones mediated significant protection against a lethal infection with Y. enterocolitica O8. These results indicate that HSP60 of Y. enterocolitica is an immunodominant antigen which is recognized by both antibodies and CD4+ alpha beta T cells. Moreover, this is the first report providing direct evidence that microbial HSP may elicit a protective immune response which is not associated with autoimmunity.
为了研究小肠结肠炎耶尔森菌的热休克蛋白(HSP)在宿主针对该病原体的免疫反应中的作用,我们克隆并表达了小肠结肠炎耶尔森菌O8血清型的一种60 kDa热休克蛋白。对由氨基酸90至286编码的小肠结肠炎耶尔森菌O8 HSP60片段进行了测序,结果显示其与小肠结肠炎耶尔森菌O3的HSP60以及大肠杆菌的GroEL有超过90%的同源性,与牛分枝杆菌的HSP65有59%的同源性。在小肠结肠炎耶尔森菌HSP60上未发现分枝杆菌HSP65的致关节炎T细胞表位(氨基酸残基180至188)。为了确定小肠结肠炎耶尔森菌HSP60是否为免疫显性抗原,分析了小肠结肠炎耶尔森菌感染的C57BL/6小鼠的免疫反应。小肠结肠炎耶尔森菌感染的小鼠针对小肠结肠炎耶尔森菌HSP60产生了显著的血清抗体和脾脏T细胞反应。从感染小肠结肠炎耶尔森菌或经小肠结肠炎耶尔森菌HSP60免疫的小鼠分离的脾脏T细胞中产生的CD4+αβT细胞克隆,识别热灭活的小肠结肠炎耶尔森菌O3和O8血清型以及重组小肠结肠炎耶尔森菌HSP60,但不识别热灭活的假结核耶尔森菌、鼠伤寒沙门菌或牛分枝杆菌的重组HSP65。HSP60反应性T细胞克隆的过继转移介导了对小肠结肠炎耶尔森菌O8致死性感染的显著保护作用。这些结果表明,小肠结肠炎耶尔森菌的HSP60是一种免疫显性抗原,可被抗体和CD4+αβT细胞识别。此外,这是第一份提供直接证据表明微生物HSP可能引发与自身免疫无关的保护性免疫反应的报告。